• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Oximes Aldoximes

Comprehensive Overview of n-Heptanal oxime (CAS No. 629-31-2): Properties, Applications, and Industry Insights

n-Heptanal oxime, with the CAS number 629-31-2, is a specialized organic compound widely recognized for its versatile applications in fragrance synthesis, agrochemicals, and industrial processes. This oxime derivative of n-heptanal exhibits unique chemical properties, making it valuable in formulations requiring controlled release or specific reactivity. As sustainability and green chemistry gain prominence, researchers are increasingly exploring bio-based oxime synthesis methods for compounds like n-Heptanal oxime to reduce environmental impact.

The molecular structure of n-Heptanal oxime (C₇H₁₅NO) features a characteristic oxime functional group (-C=N-OH), which contributes to its stability and reactivity profile. Recent studies highlight its role as a flavor and fragrance intermediate, particularly in creating citrus and green odor profiles. Industry reports indicate growing demand for high-purity oxime compounds in premium personal care products, driving innovation in purification technologies.

From a manufacturing perspective, n-Heptanal oxime production typically involves the condensation reaction between n-heptanal and hydroxylamine under controlled conditions. Advanced analytical techniques like GC-MS and HPLC are essential for quality control, especially when the compound is used in pharmaceutical intermediates or food-grade applications. Regulatory compliance with REACH and FDA guidelines remains crucial for commercial distribution.

Emerging applications for CAS 629-31-2 include its use as a corrosion inhibitor in specialty coatings and as a chelating agent in metal extraction processes. The compound's ability to form stable complexes with transition metals has sparked interest in catalytic system development and wastewater treatment technologies. Researchers are particularly focused on optimizing the oxime formation yield through novel catalysts and reaction engineering.

Market analysis reveals that n-Heptanal oxime suppliers are expanding their production capacities in response to growing demand from Asia-Pacific regions. The compound's storage stability and handling requirements remain key considerations for distributors, with recommendations for amber glass containers under nitrogen atmosphere to maintain product integrity. Technical specifications typically emphasize ≥98% purity levels for most industrial applications.

In academic circles, n-Heptanal oxime research contributes to broader understanding of oxime chemistry and molecular recognition phenomena. Recent publications explore its crystalline structure and hydrogen bonding patterns, which influence physical properties like melting point (reported between 52-55°C) and solubility characteristics. These fundamental studies support the development of new oxime derivatives with tailored properties.

The environmental profile of 629-31-2 has been evaluated through standard OECD test guidelines, showing favorable biodegradability under aerobic conditions. This aligns with industry trends toward sustainable chemical alternatives and green formulation strategies. Life cycle assessment studies are helping manufacturers optimize production routes to minimize energy consumption and byproduct formation.

Quality assurance protocols for n-Heptanal oxime typically include rigorous testing for residual aldehydes, hydroxylamine content, and heavy metal impurities. Advanced spectroscopic methods like FTIR and NMR provide structural confirmation, while Karl Fischer titration ensures appropriate moisture levels. These analytical controls are especially critical when the compound serves as a precursor for high-value specialty chemicals.

From a commercial standpoint, n-Heptanal oxime pricing fluctuates based on raw material costs (particularly n-heptanal availability) and regional demand patterns. Current market intelligence suggests increasing interest from flavor and fragrance companies seeking to diversify their ingredient portfolios with unique organoleptic compounds. Technical datasheets emphasize the compound's low volatility and compatibility with common formulation bases.

Future prospects for CAS 629-31-2 include potential applications in controlled-release systems and smart materials, leveraging the oxime group's reversible chemistry. Research collaborations between academia and industry are exploring novel derivatives with enhanced functionality, while maintaining favorable toxicological profiles. These developments position n-Heptanal oxime as a compound of continuing relevance in specialty chemical markets.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)